These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18472986)

  • 1. Prevention of shingles: safety and efficacy of live zoster vaccine.
    Quan D; Cohrs RJ; Mahalingam R; Gilden DH
    Ther Clin Risk Manag; 2007 Aug; 3(4):633-9. PubMed ID: 18472986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: The neurobiology of varicella zoster virus infection.
    Gilden D; Mahalingam R; Nagel MA; Pugazhenthi S; Cohrs RJ
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):441-63. PubMed ID: 21342215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella zoster virus latency, neurological disease and experimental models: an update.
    Cohrs RJ; Gilden DH; Mahalingam R
    Front Biosci; 2004 Jan; 9():751-62. PubMed ID: 14766405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular pathogenesis of varicella virus infection.
    Gilden DH; Cohrs RJ; Mahalingam R
    Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella virus-mononuclear cell interaction.
    White TM; Gilden DH
    Adv Virus Res; 2003; 62():1-17. PubMed ID: 14719363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variegate neurological manifestations of varicella zoster virus infection.
    Gilden D; Nagel MA; Cohrs RJ; Mahalingam R
    Curr Neurol Neurosci Rep; 2013 Sep; 13(9):374. PubMed ID: 23884722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella Zoster Virus in the Nervous System.
    Gilden D; Nagel M; Cohrs R; Mahalingam R; Baird N
    F1000Res; 2015; 4():. PubMed ID: 26918131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ; Schmader K
    Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of Varicella-Zoster Virus Infection.
    Kennedy PGE; Gershon AA
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of varicella (VZV) vaccination: an update for the clinician.
    Wang L; Zhu L; Zhu H
    Ther Adv Vaccines; 2016 Jan; 4(1-2):20-31. PubMed ID: 27551429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management.
    Christo PJ; Hobelmann G; Maine DN
    Drugs Aging; 2007; 24(1):1-19. PubMed ID: 17233544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella zoster virus vaccines: potential complications and possible improvements.
    Silver B; Zhu H
    Virol Sin; 2014 Oct; 29(5):265-73. PubMed ID: 25358998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Harpaz R; Ortega-Sanchez IR; Seward JF;
    MMWR Recomm Rep; 2008 Jun; 57(RR-5):1-30; quiz CE2-4. PubMed ID: 18528318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella-zoster virus: a re-emerging infection.
    LaGuardia JJ; Gilden DH
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):183-7. PubMed ID: 11924825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in Varicella Zoster Virus Vasculopathy.
    Nagel MA; Gilden D
    Curr Neurol Neurosci Rep; 2016 Feb; 16(2):12. PubMed ID: 26750127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.
    Mueller NH; Gilden DH; Cohrs RJ; Mahalingam R; Nagel MA
    Neurol Clin; 2008 Aug; 26(3):675-97, viii. PubMed ID: 18657721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination to prevent herpes zoster in older adults.
    Gnann JW
    J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
    Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
    Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.